possible drug-drug interactions except with oral anticoagulants.
A review of these and other inserts including propranolol (IEL Ltd., Madras), atenolol (IPCA Laboratories, Bombay), haloperidol (Searle-India Ltd., Bombay), buprenorphine (Unichem Laboratories, Bombay), piroxicam (Cadila Antibiotics Pvt. Ltd., Ahmedabad), and diazepam (Ranbaxy Laboratories, New Delhi) showed that limited information on clinical pharmacology, pharmacokinetics, adverse effects, and drug interactions is made available compared with what is available in the U.S. Furthermore, marked variation exists in the amount and type of information published in different inserts.
There was also a variability in the package information of a given product from different manufacturers. The package insert for dexamethasone sodium phosphate injection from one company (Dexona Injection, Cadila) has brief sections on description, pharmacology, indications, contraindications, administration and dosage, precautions, usage in pregnancy, adverse reactions, and presentation; the insert for the same drug from another company (Wyeth Laboratories, Bombay) provides information about composition, action, indications, dosage and administration, precautions, and how supplied. The latter package insert does not include any information about adverse effects other than "the same precautions applicable to all systemic corticosteroid therapy must be observed" under Precautions.
These observations suggest that package information is often limited and incomplete for drugs available in India. This is of special concern because the practicing pharmacists often have had no pharmacy education, nor do they have access to any standard textbooks or other reference sources.
Pharmacy associations and colleges should work together to develop some reference material on drugs. Also, governmental authorities should develop guidelines for minimum levels of information that must be included by manufacturers in their package inserts.
A comparison of drug package information made available in India versus the U.S. leads me to speculate that a significant variation exists in this source of information internationally. An organization such as the World Health Organization may play an important role in developing minimum standards for information to be supplied by all companies to assist in improving the health and welfare of patients worldwide. 
Reference

